3Park MH,Scott RL,Uber PA ,et al. Usefulness of B - type natriuret-ic peptidea predictor of treatment outcome in pulmonary arterial hy-pertension[ J]. Congest Heart Fail ,2004,10(5) :221 -225.
4Bozkanat E,Tozkoparan E,Baysan 0,et al. The significance of ele-vated brain natriuretic peptide levels in chronic obstructive pulmona-ry disease [ J]. Int Med Res,2005 ,33(5) :537 -544.
5Fabbri LM, Rabe KF. From COPD to chronic systemic inflammatory syndrome[ J]. Lancet,2007,370:797 - 799.
6Miravitlles M, Soler - Cataluna JJ, Calle M, et al. Treatment of COPD by clinical phenotypes, putting old evidence into clinical practice [ J ]. EurRespir J, 2012, 126 (11): 112-116.
7Jensen MH, Cichosz SL, Hejlesea OK, et al. Clinical impact of home telemonitoring on patients with chronic obstructive pulmonary disease [J]. Telemed J E Health, 2012, 18 (9) : 674 -678.
